Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 15/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 14/20 | 0.59 |
| ▸ | F2 | P00734 | 1/20 | 0.54 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.54 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.54 |
| ▸ | REN | P00797 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3204393 | 1.00 | OPRK1 (0.59) | OPRK1OPRM1F2NMUR2NMUR1 | |
| SCHEMBL3221767 | 0.97 | OPRK1 (0.59) | OPRK1OPRM1F2NMUR2NMUR1 | |
| SCHEMBL3221787 | 0.97 | OPRK1 (0.59) | OPRK1OPRM1F2NMUR2NMUR1 | |
| SCHEMBL3866931 | 0.96 | OPRK1 (0.58) | OPRK1OPRM1F2NMUR2NMUR1 | |
| SCHEMBL30064503 | 0.90 | OPRK1 (0.58) | OPRK1OPRM1F2OPRD1 | |
| SCHEMBL3221824 | 0.88 | OPRK1 (0.56) | OPRK1OPRM1F2NMUR2NMUR1 | |
| SCHEMBL30693080 | 0.83 | OPRM1 (0.56) | OPRK1OPRM1RENOPRD1 | |
| SCHEMBL31588354 | 0.82 | OPRM1 (0.61) | OPRK1OPRM1NMUR2NMUR1 | |
| SCHEMBL24360691 | 0.82 | OPRK1 (0.78) | OPRK1OPRM1OPRD1 | |
| SCHEMBL20769315 | 0.82 | ACE (0.58) | OPRK1OPRM1F2REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962697-B2 | Bioreponsive polymers | INTERFACE BIOLOGICS INC. (CA) | 2015-02-24 | — | — | US | disclosed |
| US-20100041771-A1 | Bioreponsive Polymers | INTERFACE BIOLOGICS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041771-A1 | Bioreponsive Polymers | PEPD, PREP, DNPEP | OPRK1 2985/4885OPRM1 3402/4885F2 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.